Skip to content
10-Q

Quarterly Report

OPKO HEALTH, INC. OPK

0001437749-25-014086

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 15, 2025 793.05M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $2.83M
Long Term Debt Q1 2025 · Dec 31, 2024 $3M
Short Term Debt Q1 2025 · Mar 31, 2025 $1.43M
Short Term Debt Q1 2025 · Dec 31, 2024 $1.38M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $428.83M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $426.58M
Current Liabilities Q1 2025 · Mar 31, 2025 $295.85M
Current Liabilities Q1 2025 · Dec 31, 2024 $193.1M
Total Liabilities Q1 2025 · Mar 31, 2025 $816.66M
Total Liabilities Q1 2025 · Dec 31, 2024 $834.76M
Current Assets Q1 2025 · Mar 31, 2025 $737.6M
Current Assets Q1 2025 · Dec 31, 2024 $662.09M
Total Assets Q1 2025 · Mar 31, 2025 $2.13B
Total Assets Q1 2025 · Dec 31, 2024 $2.2B
Stock Repurchased Q1 2025 · Mar 31, 2024 $50M
Capex Q1 2025 · Mar 31, 2024 $4.44M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$35.57M
Stockholders Equity Q1 2025 · Mar 31, 2024 $1.25B
Stockholders Equity Q1 2025 · Dec 31, 2023 $1.39B
Eps Basic Q1 2025 · Mar 31, 2024 −$0.12
Sga Expense Q1 2025 · Mar 31, 2024 $70.17M
Rd Expense Q1 2025 · Mar 31, 2024 $21.94M
Net Income Q1 2025 · Mar 31, 2024 −$81.84M
Operating Income Q1 2025 · Mar 31, 2024 −$71.47M
Gross Profit Q1 2025 · Mar 31, 2024 $42.07M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $131.62M
Revenue Q1 2025 · Mar 31, 2024 $173.69M